RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration

Sara Massone, Irene Vassallo, Manuele Castelnuovo, Gloria Fiorino, Elena Gatta, Mauro Robello, Roberta Borghi, Massimo Tabaton, Claudio Russo, Giorgio Dieci, Ranieri Cancedda, Aldo Pagano

Research output: Contribution to journalArticle

Abstract

Alternative splicing generates protein isoforms that are conditionally or differentially expressed in specific tissues. The discovery of factors that control alternative splicing might clarify the molecular basis of biological and pathological processes. We found that IL1-α-dependent up-regulation of 38A, a small ribonucleic acid (RNA) polymerase III-transcribed RNA, drives the synthesis of an alternatively spliced form of the potassium channel-interacting protein (KCNIP4). The alternative KCNIP4 isoform cannot interact with the γ-secretase complex, resulting in modification of γ-secretase activity, amyloid precursor protein processing, and increased secretion of β-amyloid enriched in the more toxic Aβ x-42 species. Notably, synthesis of the variant KCNIP4 isoform is also detrimental to brain physiology, as it results in the concomitant blockade of the fast kinetics of potassium channels. This alternative splicing shift is observed at high frequency in tissue samples from Alzheimer's disease patients, suggesting that RNA polymerase III cogenes may be upstream determinants of alternative splicing that significantly contribute to homeostasis and pathogenesis in the brain.

Original languageEnglish
Pages (from-to)851-866
Number of pages16
JournalJournal of Cell Biology
Volume193
Issue number5
DOIs
Publication statusPublished - May 30 2011

Fingerprint

Kv Channel-Interacting Proteins
Alternative Splicing
RNA
Amyloid Precursor Protein Secretases
Protein Isoforms
Brain
Biological Phenomena
Poisons
Potassium Channels
Pathologic Processes
Amyloid
Alzheimer Disease
Homeostasis
Up-Regulation
Drive

ASJC Scopus subject areas

  • Cell Biology

Cite this

RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration. / Massone, Sara; Vassallo, Irene; Castelnuovo, Manuele; Fiorino, Gloria; Gatta, Elena; Robello, Mauro; Borghi, Roberta; Tabaton, Massimo; Russo, Claudio; Dieci, Giorgio; Cancedda, Ranieri; Pagano, Aldo.

In: Journal of Cell Biology, Vol. 193, No. 5, 30.05.2011, p. 851-866.

Research output: Contribution to journalArticle

Massone, S, Vassallo, I, Castelnuovo, M, Fiorino, G, Gatta, E, Robello, M, Borghi, R, Tabaton, M, Russo, C, Dieci, G, Cancedda, R & Pagano, A 2011, 'RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration', Journal of Cell Biology, vol. 193, no. 5, pp. 851-866. https://doi.org/10.1083/jcb.201011053
Massone, Sara ; Vassallo, Irene ; Castelnuovo, Manuele ; Fiorino, Gloria ; Gatta, Elena ; Robello, Mauro ; Borghi, Roberta ; Tabaton, Massimo ; Russo, Claudio ; Dieci, Giorgio ; Cancedda, Ranieri ; Pagano, Aldo. / RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration. In: Journal of Cell Biology. 2011 ; Vol. 193, No. 5. pp. 851-866.
@article{8a6ab259f3a44c58803671121824462f,
title = "RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration",
abstract = "Alternative splicing generates protein isoforms that are conditionally or differentially expressed in specific tissues. The discovery of factors that control alternative splicing might clarify the molecular basis of biological and pathological processes. We found that IL1-α-dependent up-regulation of 38A, a small ribonucleic acid (RNA) polymerase III-transcribed RNA, drives the synthesis of an alternatively spliced form of the potassium channel-interacting protein (KCNIP4). The alternative KCNIP4 isoform cannot interact with the γ-secretase complex, resulting in modification of γ-secretase activity, amyloid precursor protein processing, and increased secretion of β-amyloid enriched in the more toxic Aβ x-42 species. Notably, synthesis of the variant KCNIP4 isoform is also detrimental to brain physiology, as it results in the concomitant blockade of the fast kinetics of potassium channels. This alternative splicing shift is observed at high frequency in tissue samples from Alzheimer's disease patients, suggesting that RNA polymerase III cogenes may be upstream determinants of alternative splicing that significantly contribute to homeostasis and pathogenesis in the brain.",
author = "Sara Massone and Irene Vassallo and Manuele Castelnuovo and Gloria Fiorino and Elena Gatta and Mauro Robello and Roberta Borghi and Massimo Tabaton and Claudio Russo and Giorgio Dieci and Ranieri Cancedda and Aldo Pagano",
year = "2011",
month = "5",
day = "30",
doi = "10.1083/jcb.201011053",
language = "English",
volume = "193",
pages = "851--866",
journal = "Journal of Cell Biology",
issn = "0021-9525",
publisher = "Rockefeller University Press",
number = "5",

}

TY - JOUR

T1 - RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration

AU - Massone, Sara

AU - Vassallo, Irene

AU - Castelnuovo, Manuele

AU - Fiorino, Gloria

AU - Gatta, Elena

AU - Robello, Mauro

AU - Borghi, Roberta

AU - Tabaton, Massimo

AU - Russo, Claudio

AU - Dieci, Giorgio

AU - Cancedda, Ranieri

AU - Pagano, Aldo

PY - 2011/5/30

Y1 - 2011/5/30

N2 - Alternative splicing generates protein isoforms that are conditionally or differentially expressed in specific tissues. The discovery of factors that control alternative splicing might clarify the molecular basis of biological and pathological processes. We found that IL1-α-dependent up-regulation of 38A, a small ribonucleic acid (RNA) polymerase III-transcribed RNA, drives the synthesis of an alternatively spliced form of the potassium channel-interacting protein (KCNIP4). The alternative KCNIP4 isoform cannot interact with the γ-secretase complex, resulting in modification of γ-secretase activity, amyloid precursor protein processing, and increased secretion of β-amyloid enriched in the more toxic Aβ x-42 species. Notably, synthesis of the variant KCNIP4 isoform is also detrimental to brain physiology, as it results in the concomitant blockade of the fast kinetics of potassium channels. This alternative splicing shift is observed at high frequency in tissue samples from Alzheimer's disease patients, suggesting that RNA polymerase III cogenes may be upstream determinants of alternative splicing that significantly contribute to homeostasis and pathogenesis in the brain.

AB - Alternative splicing generates protein isoforms that are conditionally or differentially expressed in specific tissues. The discovery of factors that control alternative splicing might clarify the molecular basis of biological and pathological processes. We found that IL1-α-dependent up-regulation of 38A, a small ribonucleic acid (RNA) polymerase III-transcribed RNA, drives the synthesis of an alternatively spliced form of the potassium channel-interacting protein (KCNIP4). The alternative KCNIP4 isoform cannot interact with the γ-secretase complex, resulting in modification of γ-secretase activity, amyloid precursor protein processing, and increased secretion of β-amyloid enriched in the more toxic Aβ x-42 species. Notably, synthesis of the variant KCNIP4 isoform is also detrimental to brain physiology, as it results in the concomitant blockade of the fast kinetics of potassium channels. This alternative splicing shift is observed at high frequency in tissue samples from Alzheimer's disease patients, suggesting that RNA polymerase III cogenes may be upstream determinants of alternative splicing that significantly contribute to homeostasis and pathogenesis in the brain.

UR - http://www.scopus.com/inward/record.url?scp=79959453425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959453425&partnerID=8YFLogxK

U2 - 10.1083/jcb.201011053

DO - 10.1083/jcb.201011053

M3 - Article

C2 - 21624954

AN - SCOPUS:79959453425

VL - 193

SP - 851

EP - 866

JO - Journal of Cell Biology

JF - Journal of Cell Biology

SN - 0021-9525

IS - 5

ER -